中国多黏菌素类抗菌药物临床合理应用多学科专家共识

2021-04-12 中国医药教育协会感染疾病专业委员会 中华结核和呼吸杂志, 2021,44(04)

多黏菌素类抗菌药物问世于20世纪50年代末,后来因同样有效但更安全的新药不断问世而逐渐淡出临床。到了20世纪80年代,随着多重耐药革兰阴性菌的增多,此类药物重新受到重视而重返临床。但由于其上市时间早,

中文标题:

中国多黏菌素类抗菌药物临床合理应用多学科专家共识

发布日期:

2021-04-12

简要介绍:

多黏菌素类抗菌药物问世于20世纪50年代末,后来因同样有效但更安全的新药不断问世而逐渐淡出临床。到了20世纪80年代,随着多重耐药革兰阴性菌的增多,此类药物重新受到重视而重返临床。但由于其上市时间早,至今仍有许多问题给临床造成困惑。因此,由中国医药教育协会感染疾病专业委员会牵头,联合多学科相关领域著名专家与权威学术组织共同编写本共识,全文以问答的方式展示,分为11个部分,37个问题,10条推荐意见,希望为临床医生合理应用多黏菌素类药物提供切实可行的参考。

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国多黏菌素类抗菌药物临床合理应用多学科专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=599881c002161585, title=中国多黏菌素类抗菌药物临床合理应用多学科专家共识, enTitle=, guiderFrom=中华结核和呼吸杂志, 2021,44(04), authorId=0, author=, summary=多黏菌素类抗菌药物问世于20世纪50年代末,后来因同样有效但更安全的新药不断问世而逐渐淡出临床。到了20世纪80年代,随着多重耐药革兰阴性菌的增多,此类药物重新受到重视而重返临床。但由于其上市时间早,, cover=https://img.medsci.cn/2021824/1629814617213_2020535.jpg, journalId=0, articlesId=null, associationId=1353, associationName=中国医药教育协会感染疾病专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Mon Apr 12 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="article_abstract" style="color: #2c3e50;" data-v-da075436=""><span data-v-da075436="">多黏菌素类抗菌药物问世于20世纪50年代末,后来因同样有效但更安全的新药不断问世而逐渐淡出临床。到了20世纪80年代,随着多重耐药革兰阴性菌的增多,此类药物重新受到重视而重返临床。但由于其上市时间早,至今仍有许多问题给临床造成困惑。因此,由中国医药教育协会感染疾病专业委员会牵头,联合多学科相关领域著名专家与权威学术组织共同编写本共识,全文以问答的方式展示,分为11个部分,37个问题,10条推荐意见,希望为临床医生合理应用多黏菌素类药物提供切实可行的参考。</span></div>, tagList=[TagDto(tagId=114153, tagName=多黏菌素类)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=5642, guiderKeyword=抗菌药物, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5461, appHits=121, showAppHits=0, pcHits=987, showPcHits=5339, likes=1, shares=5, comments=8, approvalStatus=1, publishedTime=Tue Aug 24 23:49:52 CST 2021, publishedTimeString=2021-04-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Aug 24 22:17:11 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 06:48:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国多黏菌素类抗菌药物临床合理应用多学科专家共识.pdf)])
中国多黏菌素类抗菌药物临床合理应用多学科专家共识.pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1239698, encodeId=3e861239698c9, content=十分感谢+10086, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:20:54 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239697, encodeId=b1b8123969e99, content=非常好的资料,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:20:42 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225406, encodeId=511a122540686, content=学习了,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68516496509, createdName=呼气阀, createdTime=Thu Jun 09 11:52:30 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181858, encodeId=de011181858f2, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Fri Jan 07 15:06:19 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083212, encodeId=e45f108321238, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6c25568576, createdName=ms3000000897064523, createdTime=Wed Dec 22 21:04:37 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-08-19 hai海

    十分感谢+10086

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1239698, encodeId=3e861239698c9, content=十分感谢+10086, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:20:54 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239697, encodeId=b1b8123969e99, content=非常好的资料,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:20:42 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225406, encodeId=511a122540686, content=学习了,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68516496509, createdName=呼气阀, createdTime=Thu Jun 09 11:52:30 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181858, encodeId=de011181858f2, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Fri Jan 07 15:06:19 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083212, encodeId=e45f108321238, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6c25568576, createdName=ms3000000897064523, createdTime=Wed Dec 22 21:04:37 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-08-19 hai海

    非常好的资料,谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1239698, encodeId=3e861239698c9, content=十分感谢+10086, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:20:54 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239697, encodeId=b1b8123969e99, content=非常好的资料,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:20:42 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225406, encodeId=511a122540686, content=学习了,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68516496509, createdName=呼气阀, createdTime=Thu Jun 09 11:52:30 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181858, encodeId=de011181858f2, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Fri Jan 07 15:06:19 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083212, encodeId=e45f108321238, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6c25568576, createdName=ms3000000897064523, createdTime=Wed Dec 22 21:04:37 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-06-09 呼气阀

    学习了,非常好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1239698, encodeId=3e861239698c9, content=十分感谢+10086, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:20:54 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239697, encodeId=b1b8123969e99, content=非常好的资料,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:20:42 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225406, encodeId=511a122540686, content=学习了,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68516496509, createdName=呼气阀, createdTime=Thu Jun 09 11:52:30 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181858, encodeId=de011181858f2, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Fri Jan 07 15:06:19 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083212, encodeId=e45f108321238, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6c25568576, createdName=ms3000000897064523, createdTime=Wed Dec 22 21:04:37 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-01-07 ms7000000167247375

    学习#学习#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1239698, encodeId=3e861239698c9, content=十分感谢+10086, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:20:54 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239697, encodeId=b1b8123969e99, content=非常好的资料,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:20:42 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225406, encodeId=511a122540686, content=学习了,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68516496509, createdName=呼气阀, createdTime=Thu Jun 09 11:52:30 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181858, encodeId=de011181858f2, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Fri Jan 07 15:06:19 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083212, encodeId=e45f108321238, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6c25568576, createdName=ms3000000897064523, createdTime=Wed Dec 22 21:04:37 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 ms3000000897064523

    👍

    0

拓展阅读

2016 BSAC/EWMA意见书:创伤护理中抗菌药物管理

英国抗菌化疗学会(BSAC,British Society for Antimicrobial Chemotherapy) · 2016-07-25

抗菌药物药代动力学/药效学理论临床应用专家共识

中国医药教育协会感染疾病专业委员会 · 2018-06-20

2018 STM专家共识:抗菌药物在胸外科的应用

转化医学学会(STM,Society for Translational Medicine) · 2018-11-30

胆道外科抗菌药物规范化应用专家共识(2019版)

中华医学会外科学分会胆道外科学组 · 2019-07-25